Inflammation & Allergy - Drug Targets (Discontinued)

Kurt S Zaenker
Institute of Immunology and Experimental Oncology
University Witten/Herdecke
Stockumerstraße 10
Witten, 58448
Germany

View Full Editorial Board

Inflammation & Allergy - Drug Targets (Discontinued)

Formerly: 'Current Drug Targets - Inflammation & Allergy

Contents

Inflammation & Allergy - Drug Targets (Discontinued), Volume 6 - Number 1

Author Index To Volume 5

Bentham Science Publishers

Subject Index To Volume 5

Bentham Science Publishers

Editorial

James L. Ellis

T Lymphocytes as Targets of Statins: Molecular Mechanisms and Therapeutic Perspectives

Raffaella Ghittoni, Pietro Enea Lazzerini, Franco Laghi Pasini and Cosima T. Baldari

Highly Selective Phosphodiesterase 4 Inhibitors for the Treatment of Allergic Skin Diseases and Psoriasis

Wolfgang Baumer, Joachim Hoppmann, Chris Rundfeldt and Manfred Kietzmann

New Insights on the Nature of Latent Tuberculosis Infection and its Treatment

Pere-Joan Cardona

Vascular Remodelling and Angiogenesis in Asthma: Morphological Aspects and Pharmacological Modulation

Alfredo Chetta, Andrea Zanini, Olga Torre and Dario Olivieri

Biological Variability and Targeted Delivery of Therapeutics for Inflammatory Bowel Diseases: An In Silico Approach

Nahor Haddish-Berhane, Ashkan Farhadi, Chell Nyquist, Kamyar Haghighi and Ali Keshavarzian

Targeting Kit Activation: A Potential Therapeutic Approach in the Treatment of Allergic Inflammation

Bettina M. Jensen, Dean D. Metcalfe and Alasdair M. Gilfillan

Role of Interleukin-21 in Inflammation and Allergy

Daniele Fina, Massimo Claudio Fantini, Francesco Pallone and Giovanni Monteleone

Therapeutic Targeting of P-Selectin in Atherosclerosis

Kevin J. Woollard and Jaye Chin-Dusting

Editor-in-Chief

Quick Links

Related Journals

Related eBooks

eBooks Catalog